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Introduction 
Many in the health policy community are highly critical of the European Union and its involvement in 
health. CﾉWﾏWﾐゲ Wデ ;ﾉげゲ ヮ;ヮWヴ ｷゲ ; ヴWaヴWゲｴｷﾐｪﾉ┞ H;ﾉ;ﾐIWS ;ﾐ;ﾉ┞ゲｷゲ ;ﾐS ;ゲゲWゲゲﾏWﾐデく Iデ summarises the 
けゲデ;ﾐS;ヴS ﾐ;ヴヴ;デｷ┗Wげ ﾗa デｴW SWデヴｷﾏWﾐデ;ﾉ ｷﾏヮ;Iデゲ ﾗa EU ﾉ;┘ ;ﾐS ヮﾗﾉｷI┞ ﾗﾐ ﾐ;デｷﾗﾐ;ﾉ ｴW;ﾉデｴ ゲ┞ゲデWﾏゲ. But 
it also illuminates an ｷﾏヮﾗヴデ;ﾐデ Iﾗ┌ﾐデWヴH;ﾉ;ﾐIW ﾗa けｴｷSSWﾐげ ;ゲヮWIデゲ ﾗa EU ｴW;ﾉデｴ ヮﾗﾉｷI┞く These have 
the potential to improve health across the EU, even in the post-crisis era of public spending austerity. 
The conclusion に デｴ;デ ﾗﾐ H;ﾉ;ﾐIW けEU ｷﾐ┗ﾗﾉ┗WﾏWﾐデ I;ﾐ ;SS Hｷ;ゲWゲ ;ﾐS ヮヴﾗHﾉWﾏゲ ヮヴW┗ｷﾗ┌ゲﾉ┞ ┌ﾐﾆﾐﾗ┘ﾐ 
;デ ﾐ;デｷﾗﾐ;ﾉ ﾉW┗Wﾉゲげ ふCﾉWﾏWﾐゲ Wデ ;ﾉが ヲヰヱヴぶ に is thus more persuasive than that in other analyses. 
This commentary considers three inter-related ;ゲヮWIデゲ ﾗa CﾉWﾏWﾐゲ Wデ ;ﾉげゲ ヮｷWIWぎ デｴW ゲIﾗヮW ﾗa Wﾐケ┌ｷヴ┞き 
the multiple logics of EU health policy; and the Europeanisation of health, following the Eurozone 
Iヴｷゲｷゲが ┘ｴｷIｴ ｴ;ゲ ｴ;S ゲｷｪﾐｷaｷI;ﾐデ WaaWIデゲ ﾗﾐ ｴW;ﾉデｴ ヮﾗﾉｷIｷWゲ ┘ｷデｴｷﾐ デｴW EUげゲ MWﾏHWヴ States (Fahy 2012; 
Kentikelenis and Papanicolas 2012; Greer 2014). 
 
Core areas/scope of EU health policy 
TｴW ヮ;ヮWヴげゲ exploration of EU health policy rests on five selected EU policies with a health dimension. 
TｴWゲW ;ヴWぎ ヮ;デｷWﾐデ ;ﾐS ｴW;ﾉデｴ ヮヴﾗaWゲゲｷﾗﾐ;ﾉ ﾏﾗHｷﾉｷデ┞き け;Iデｷ┗W ;ｪWｷﾐｪげき デｴW ヮ┌HﾉｷI ｴW;ﾉデｴ け;Iデｷﾗﾐ 
ヮヴﾗｪヴ;ﾏﾏWげき EU ゲデヴ┌Iデ┌ヴ;ﾉ a┌ﾐSｷﾐｪ aﾗヴ WIﾗﾐﾗﾏｷI SW┗WﾉﾗヮﾏWﾐデき ;ﾐS けヴWaﾉWIデｷﾗﾐ ヮヴﾗIWゲゲWゲげ ;ﾏﾗﾐｪ 
senior governmental actors. Implicitly, Clemens et al claim that these are, if not the core of EU 
health policy, at least a sufficiently representative selection of examples from which to generalise 
about EU health policy.  
Comparing this choice of examples (and claims) with the literature on EU health law and policy 
reve;ﾉゲ デｴ;デ CﾉWﾏWﾐゲ ;デ ;ﾉげゲ IｴﾗｷIW SWヮ;ヴデゲ aヴﾗﾏ W┝ｷゲデｷﾐｪ ﾉｷデWヴ;デ┌ヴW ｷﾐ ゲW┗Wヴ;ﾉ ヴWゲヮWIデゲ. Historically, 
public health policy enjoys a more ｷﾏヮﾗヴデ;ﾐデ ヮﾗゲｷデｷﾗﾐ デｴ;ﾐ ｷﾐ CﾉWﾏWﾐゲげ Wデ ;ﾉげゲ piece, which covers 
only the EU public health programmes. General EU public health policy has a much wider meaning 
and significance. It interacts with the law of the internal market, as well as World Trade Organisation 
law about trade in products which are, or may be, harmful for health, such as tobacco or alcohol 
(Hervey and McHale 2004; McKee et al 2010; Hervey and McHale 2015). The role of food in public 
health, especially as Europe emerged from the starvation following World War II, means that the 
EUげゲ Iﾗﾏﾏﾗﾐ ;ｪヴｷI┌ﾉデ┌ヴ;ﾉ ヮﾗﾉｷI┞ ｷゲ ;ﾐ ｷﾏヮﾗヴデ;ﾐデ ゲｷデW aﾗヴ ｷデゲ ｴW;ﾉデｴ ヮﾗﾉｷI┞く FﾗﾗS ゲafety has become a 
┗ｷデ;ﾉ ヮ;ヴデ ﾗa デｴW EUげゲ ｴW;ﾉデｴ ヮヴﾗデWIデｷﾗﾐ ヮﾗﾉｷI┞が WゲヮWIｷ;ﾉﾉ┞ aﾗﾉﾉﾗ┘ｷﾐｪ デｴW BSEっ┗CJD ;aa;ｷヴ ﾗa デｴW ヱΓΓヰゲ 
(Grant 2012).  Early texts on EU health policy (such as McCarthy and Rees 1992) are only on public 
health, and interest continues (Greer and Kurzer 2013).   
Also dating to the EUげゲ foundational period, pharmaceutical policy continues to be central to EU 
health policy (Hermans et al 1992; Normand and Vaughan 2001; Busse et al 2002; Hervey 2002; 
McKee et al 2003; Mossialos and McKee 2004; Hervey and McHale 2004; Mossialos et al 2010; 
Hancher and Sauter 2012; Greer and Kurzer 2013). Recent developments in pharmaceuticals and 
medical devices technology (Flear et al 2013) mean that EU policy on human blood, tissue and 
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organs is important (Hervey and Black 2005; Lee 2010; Altenstetter 2011; Farrell 2012; Stokes 2013; 
Flear 2015).  In the post-crisis Europe, as Clemens et al note, new health technologies are 
constructed as contributing to economic development and growth at least as much as to health per 
se. But the regulation of the human body also ｴ;ゲ ｷﾐデWヴ;Iデｷﾗﾐゲ ┘ｷデｴ E┌ヴﾗヮWげゲ ﾉﾗﾐｪ-standing 
commitment to human rights (Hervey 2003; McHale 2010; Herrmann and Toebes 2012; Harmon et 
al 2013; Peers et al 2014), a part of EU health policy not considered by Clemens et al. 
There is general agreement that EU health policy includes mobility of patients and health care 
professionals, and the consequences of EU free movement and competition law for national health 
care systems (Mossialos et al 2002; Hervey and McHale 2004; Nihoul and Simon 2005; Thomson et al 
2009; Mossialos et al 2010; Van de Gronden et al 2011; Hancher and Sauter, 2012; Greer and Kurzer 
2013; Hervey and McHale 2015). A small, but growing, body of literature (Jarman 2013, 2014; 
Hervey and McHale 2015) is concerned with the external WaaWIデゲ ﾗa デｴW EUげゲ ｴW;ﾉデｴ ヮﾗﾉｷI┞ に how does 
mobility into and out of the EU of people and products related to health play out in the rest of the 
world? This latter aspect of the effects of trade and competition on EU health policy also falls 
ﾗ┌デゲｷSW デｴW ゲIﾗヮW ﾗa CﾉWﾏWﾐゲ Wデ ;ﾉげゲ ヮｷWIWく 
Although Clemens et al do not adopt as wide a scope as sketched here, their focus, excluding areas 
such as human rights in health policies, public health protection, and the EUげゲ ｪﾉﾗH;ﾉ ｴW;ﾉデｴ ヮﾗﾉｷIｷWゲが 
is sufficiently wide for their conclusions to be persuasive nonetheless.  
 
Multiple logics of EU health policy 
Clemens et al stress how their examples highlight multiple logics inherent in EU health policy. They 
note that に contヴ;ヴ┞ デﾗ デｴW ｪWﾐWヴ;ﾉ デWﾐﾗヴ ﾗa デｴW ｴW;ﾉデｴ ヮﾗﾉｷI┞ Iﾗﾏﾏ┌ﾐｷデ┞げゲ ┗ｷW┘ゲ に no dominant 
ﾐ;ヴヴ;デｷ┗W aﾗヴ SｷゲI┌ゲゲｷﾐｪ EU ｴW;ﾉデｴ ヮﾗﾉｷI┞ ｴ;ゲ ┞Wデ WﾏWヴｪWSく TｴW SｷゲIﾗ┌ヴゲW ﾗa けIﾗﾐゲデｷデ┌デｷﾗﾐ;ﾉ 
;ゲ┞ﾏﾏWデヴ┞げ ふデｴ;デ デｴW EUげs powers to Europeanize economic policies are more complete than those 
for social policies) runs strong in EU health policy. But other logics are also expressed. Furthermore, 
it is not clear whether けhealthげ Iﾗ┌ﾐデゲ ;ゲ ﾗﾐﾉ┞ けゲﾗIｷ;ﾉげ ﾗヴ ;ﾉゲﾗ ;ゲ けWIﾗﾐﾗﾏｷIげく  
In our forthcoming book (2015), McHale and I also approach EU health through multiple logics. We 
consider the themes of consumerism; (human) rights; interfaces between competition, solidarity 
and equality; and risk. We isolate, compare and contrast an individual perspective and a systemic or 
IﾗﾉﾉWIデｷ┗W ヮWヴゲヮWIデｷ┗Wが ;ﾐS ┘W IﾗﾐゲｷSWヴ デｴW EUげゲ ｷﾐデWヴﾐ;ﾉ ｴW;ﾉデｴ ﾉ;┘ ;ﾐS ｷデゲ ｷﾐデWヴ;Iデｷﾗﾐゲ ┘ｷデｴ ｪﾉﾗH;ﾉ 
health law.  Like Clemens et al, we find support for the standard narrative about EU health law and 
policy. We conclude that opportunities for EU health policy to improve health are missed. In Europe, 
the values of solidarity and equality of access according to medical need underpin health systems に 
and it follows that opposing values, such as mobility, consumer choice or competition, or risk within 
a market, sit ill with health policy communities.  But we also find に in common with Clemens et al に 
that the dominant narrative is not the whole of the story.  EU health policy itself expresses and 
embodies a range of values.  
 
Europeanisation of health policy 
Iゲ ｴW;ﾉデｴ ヮﾗﾉｷI┞ HWIﾗﾏｷﾐｪ けE┌ヴﾗヮW;ﾐｷゲWSげい The answer depends upon how the scope of health policy 
is drawn. It is highly improbable that EU health policy will ever have the same substantive scope or 
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dominant focus as national health policies.  But the EU at least touches upon virtually every aspect 
of such policies.  In some areas (such as pharmaceuticals regulation), policies and laws are entirely 
EU-determined.  By contrast, in others (such as end-of-life care), the EU (as opposed to the Council 
of Europe) barely has any influence at all.  It is equally improbable that EU health policy will emerge 
;ゲ ; ゲｷﾏヮﾉW ヴWｪｷﾗﾐ;ﾉ ┗;ヴｷ;ﾐデ ﾗa ｪﾉﾗH;ﾉ ｴW;ﾉデｴく  A SｷゲデｷﾐIデｷ┗Wﾉ┞ けE┌ヴﾗヮW;ﾐげ ;ヮヮヴﾗ;Iｴ デﾗ デｴW ﾏﾗSｷaｷI;デｷﾗﾐ 
of liberal global trade involves conceptualising health as a productive factor in economic growth, but 
also embodies human-rights conditionality, elements of an ethic of equality, and risk-based 
consumer protection, particular from products known to be dangerous to health and costly for 
national health systems. 
 
Conclusion 
CﾉWﾏWﾐゲ Wデ ;ﾉ IﾗﾐIﾉ┌SW デｴ;デ ｷデ ｷゲ デﾗﾗ ゲﾗﾗﾐ デﾗ ゲ;┞ ┘ｴWデｴWヴ デｴW けヮ;デIｴ┘ﾗヴﾆげ ﾗa EU ｴW;ﾉデｴ ヮﾗﾉｷI┞ ｷゲ 
becoming ever more coherent, and we are seeing a process of Europeanisation, or whether the 
policy field will remain driven by multiple logics. I would say that the two are not mutually exclusive: 
we are seeing Europeanisation of a policy area that is driven by one dominant (and other subsidiary) 
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